Mr. Speaker, I would like to thank my colleague for her question. She is absolutely correct. The parliamentary secretary has also said that the laboratories are not against the bill.
The laboratories are conscious of the risks that their activities pose to public health. However, my colleague rightly pointed out, they are asking how they, with the financial resources they currently have, will be able to adapt their practices and, as I said earlier, not cause any incidents. No incidents have been recorded in Quebec or in Canada. They are wondering how they will absorb the cost—billions of dollars for all of the laboratories. How will they absorb this?
My colleague is right to be worried when she suggests that cuts might have to be made elsewhere in order to obey the law. When there is a finite amount of funding for the work to be done, it is obvious that spending on unanticipated items means cuts elsewhere.
She is also quite right to say that when this bill is studied in committee, it will be very important to hear the stakeholders' concerns clearly and directly from them. Furthermore, we will ensure that this bill includes satisfactory answers for these people, and not simply some future regulatory framework without apparent guidelines or content. Clearly, there must be a balance between safety and research.